Ghannam Malik, Manousakis Georgios
Department of Neurology, University of Minnesota, Minneapolis, MN, United States.
Front Neurol. 2020 Nov 25;11:571716. doi: 10.3389/fneur.2020.571716. eCollection 2020.
Involvement of cardiac muscle is felt to be very uncommon in anti-HMGCR myopathy, and therefore early cardiac evaluation is not considered a high priority for this condition. We herein present the case of a 72 year-old woman admitted due to dyspnea and orthopnea, who, in retrospect, suffered from proximal more than distal muscle weakness for 3 months prior to admission. She was found to have acute systolic heart failure. Serologic testing showed positive 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) IgG antibodies, and muscle biopsy showed necrotizing myopathy. No alternative explanation for heart failure was found. Despite immunotherapy and symptomatic treatment, she died from multiorgan failure. Our study suggests that heart failure in anti HMGCR myopathy may not be as rare as previously thought, and therefore early cardiac evaluation should be considered in patients with this diagnosis, to minimize morbidity and mortality.
心肌受累在抗3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCR)肌病中被认为非常罕见,因此对于这种疾病,早期心脏评估不被视为高度优先事项。我们在此报告一例72岁女性患者,因呼吸困难和端坐呼吸入院,回顾病史,她在入院前3个月近端肌无力比远端更明显。她被诊断为急性收缩性心力衰竭。血清学检测显示3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCR)IgG抗体阳性,肌肉活检显示坏死性肌病。未发现心力衰竭的其他原因。尽管进行了免疫治疗和对症治疗,她仍死于多器官功能衰竭。我们的研究表明,抗HMGCR肌病中的心力衰竭可能并不像之前认为的那么罕见,因此对于诊断为此病的患者应考虑早期心脏评估,以尽量降低发病率和死亡率。